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Editorial
All aboard the 
nitride bus
There is a well-worn phrase in England 
about waiting for London buses – none 
to be seen and then four come along at 
once. It’s been a bit like that for nitride of 
late. The past few weeks must have been 
one of the busiest ever times for nitride 
devices. Usually the news is full of opto 
but this time it is the turn of microelec-
tronics to take the stage. There have been 
some pretty impressive news items in the 
form of new power devices based on wide 
bandgap semiconductors: SiC and III-
nitrides. What was less surprising was that 
they came from the usual suspects, Cree, 
Nitronex, Toshiba and one less so, STM.
The point is that, at long last, it would 
seem that nitride transistors have come 
of age. As you will read here, it has even 
reached the hallowed corridors of the 
UK MoD. The powers that be are wor-
ried about this strategically important 
technology and the local lack of it. It may, 
however, be too late to catch up given the 
impressive pace of progress elsewhere.
For example, Cree Inc., says it is shipping 
sample quantities of its new 15 W pack-
aged GaN HEMT, the CGH27015, targeting 
WiMAX and broadband wireless. Nitronex 
launched the first three members of a fam-
ily of discrete RF devices for WiMAX. Just 
as November began, Cree added two more 
power HEMTs.
Another high-profile deal is the transatlan-
tic one struck between STMicroelectronics 
and GaN transistor manufacturer Velox 
Semiconductor. They are going to jointly 
launch high-voltage GaN Schottky diode 
products. 
Toshiba reckons it has beaten output power 
records for an X-band GaN FET. Moreover, 
it has recorded a power density six times 
larger than that of an equivalent GaAs FET. 
Better still, samples are now available 
having output powers of 50 W. It says it 
plans to start mass production next year.
This issue also has its fair share of nitride-
based features. The matter of finding the 
best substrate is timely given the number 
of interested parties in the news. This arti-
cle is just about US interests but there are 
some major developments in Europe, such 
as in Warsaw, and in the Far East. Shimei 
Semiconductor, a start-up company based 
in Kyoto, is reported to have developed a 
blue LED using GaN-on-silicon epitaxy. 
Some may be circumspect about this form 
of heteroepitaxy but it has been around 
for a year or so and has some pretty hefty 
backers. Sigantic was likely the first seri-
ous commercialisation of nitride-on-silicon 
but mainly in microelectronics, and inter-
est in this as a product is high. Nitronex 
GaN-on-silicon manufacturing process was 
recently fully qualified for volume produc-
tion and has already launched the first 
high-performance RF power transistors for 
the WiMAX market.
Of course, this epitaxy technique under-
pins the entire short wavelength LED 
industry success but it has always been 
problematic for GaAs-on-Si. Not so long 
ago Motorola introduced what seemed to 
be a practical solution for III-Vs-on-silicon 
but sadly this has yet to reach any 
significant commercialisation.
Roy Szweda, Acting Editor
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